Zhou Rong Ping, Mummaneni Praveen V, Chen Kai-Yuan, Lau Darryl, Cao Kai, Amara Dominic, Zhang Can, Dhall Sanjay, Chou Dean
Department of Orthopedics, The Second Affiliated Hospital of Nan Chang University, Nan Chang, China; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
World Neurosurg. 2019 Mar;123:e371-e378. doi: 10.1016/j.wneu.2018.11.172. Epub 2018 Nov 27.
To retrospectively analyze the outcomes and complications of patients with metastatic thoracic spinal tumors (MTTs) who underwent posterior corpectomies.
Ninety patients with MTTs who underwent posterior corpectomies were retrospectively analyzed. Characteristics evaluated included number of MTTs per year, location, involved vertebrae numbers, sex, histology, pre- and postoperative American Spinal Injury Association (ASIA) grade, visual analog scale (VAS) pain scores, operative time, blood loss, and length of hospital stay.
The average follow-up was 20.8 ± 27.9 months (range, 0.5-139.4 months). Of the patients, 76.67% had a single metastasis and 23.33% had multiple metastases. For histology, 16.67% were breast, 15.56% were lung, 12.22% were prostate, and 12.22% were renal cell carcinoma. Of the patients with paraplegia and paraparesis, 74% improved. One patient improved from ASIA grade A to D, 3 patients improved from grade B to C, 8 patients improved from grade C to D or E, and 25 patients improved from grade D to E. Three patients (6%) with ASIA grade A and 1 patient (2%) with ASIA grade B had no improvement. One patient with ASIA grade C and 8 patients (16%) with grade D had no improvement. After surgery, VAS pain scores decreased from 8.45 ± 1.57 to 1.211 ± 1.81. In terms of complications, 2 patients (2.22%) had deep vein thrombosis and 1 patient had pulmonary embolism (1.11%). Other complications included wound infection (4.44%), cerebrospinal fluid leak (4.44%), pleural effusion (3.33%), wound dehiscence (2.22%), cellulitis (1.11%), epidural hematoma (1.11%), and pneumothorax (1.11%). Of the patients, 2.22% had implant failure and pseudoarthrosis, with 1 patient needing revision surgery. One patient (1.11%) had tumor recurrence.
Our results suggest that posterior thoracic corpectomies for MTTs have a reasonable complication rate with favorable outcomes.
回顾性分析接受后路椎体次全切除术的转移性胸椎肿瘤(MTT)患者的手术结果及并发症。
回顾性分析90例接受后路椎体次全切除术的MTT患者。评估的特征包括每年MTT的数量、位置、受累椎体数量、性别、组织学类型、术前及术后美国脊髓损伤协会(ASIA)分级、视觉模拟评分(VAS)疼痛评分、手术时间、失血量及住院时间。
平均随访时间为20.8±27.9个月(范围0.5 - 139.4个月)。患者中,76.67%为单发转移,23.33%为多发转移。组织学类型方面,16.67%为乳腺癌,15.56%为肺癌,12.22%为前列腺癌,12.22%为肾细胞癌。截瘫和轻瘫患者中,74%病情改善。1例患者从ASIA A级改善至D级,3例从B级改善至C级,8例从C级改善至D级或E级,25例从D级改善至E级。3例(6%)ASIA A级患者和1例(2%)ASIA B级患者无改善。1例ASIA C级患者和8例(16%)D级患者无改善。术后,VAS疼痛评分从8.45±1.57降至1.211±1.81。并发症方面,2例(2.22%)发生深静脉血栓,1例发生肺栓塞(1.11%)。其他并发症包括伤口感染(4.44%)、脑脊液漏(4.44%)、胸腔积液(3.33%)、伤口裂开(2.22%)、蜂窝织炎(1.11%)、硬膜外血肿(1.11%)和气胸(1.11%)。患者中,2.22%发生内植物失败和假关节形成,1例患者需要翻修手术。1例患者(1.11%)发生肿瘤复发。
我们的结果表明,MTT的后路胸椎椎体次全切除术并发症发生率合理,手术结果良好。